Measurement of Cancer-Related Risk Perception in Smokers

NCT ID: NCT00588211

Last Updated: 2022-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1514 participants

Study Classification

OBSERVATIONAL

Study Start Date

2001-09-30

Study Completion Date

2022-09-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of the study is to develop and provide initial evidence for the reliability and validity of a measure of cancer-related risk perception. As such, the primary outcomes of the study will be initial construct validity (convergent validity and discriminant validity) of the proposed scale as evidenced by correlations of this test with other tests that vary in the degree of association to the proposed construct of cancer-related risk perception. It is anticipated that the cancer-related risk perception scale will correlate most highly (.50-.60) with measures of tobacco and environmental risk exposures, readiness to quit smoking, and family cancer history.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Related-Risks Risk Perception Survey Focus Group

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

We will recruit fifteen New York University College of Dentistry (NYUCD) clinic patients who report current tobacco use.

Interviews

Intervention Type BEHAVIORAL

45-minute individual interviews after the conclusion of their dental appointment

2

Second, we will recruit thirty dental clinic smokers (10 per day for 3 days) from the NYUCD waiting room.

focus group

Intervention Type BEHAVIORAL

A focus group of the preliminary cancer-related risk perception item pool.

3

Third, we will survey 200 student participants from Adelphi University.

Survey

Intervention Type BEHAVIORAL

Quantitative item analysis of the final item pool.

4

Queens Hospital Center with 800 patients.

Survey

Intervention Type BEHAVIORAL

A second confirmatory factor analysis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interviews

45-minute individual interviews after the conclusion of their dental appointment

Intervention Type BEHAVIORAL

focus group

A focus group of the preliminary cancer-related risk perception item pool.

Intervention Type BEHAVIORAL

Survey

Quantitative item analysis of the final item pool.

Intervention Type BEHAVIORAL

Survey

A second confirmatory factor analysis.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject must be \>= to 18 years of age
* For recruitment at Adelphi University: Speak English
* For recruitment at Queens Hospital Center: Speak English
* For recruitment at Queens Hospital Center: Must be a Queens Hospital Center Patient

Exclusion Criteria

* Patients who have a history of colorectal cancer at the Queens Hospital Center
* Patients who cannot give informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Adelphi University

OTHER

Sponsor Role collaborator

Queen's Hospital Center

OTHER

Sponsor Role collaborator

Memorial Sloan Kettering Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennifer L Hay, PhD

Role: PRINCIPAL_INVESTIGATOR

Memorial Sloan Kettering Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Queens Hospital Center

Jamaica, New York, United States

Site Status

New York University, College of Dentistry

New York, New York, United States

Site Status

Memorial Sloan-Kettering Cancer Center

New York, New York, United States

Site Status

Adelphi University

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mskcc.org

Memorial Sloan-Kettering web site

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CA93182

Identifier Type: -

Identifier Source: secondary_id

01-121

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Motivating Change in Aging Smokers
NCT05194917 COMPLETED NA
Connection to Health for Smokers
NCT03680599 COMPLETED NA
Tobacco Use Treatment in Cancer Patients
NCT03482583 COMPLETED PHASE4